Nanopublication

< Home

ID

http://purl.org/np/RAmwcqsxCeb1ncYsvxpKIuP_kRnM5oWXoWLShRn3uDFsM

Formats

.trig | .trig.txt | .jelly | .jelly.txt

Content

@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAmwcqsxCeb1ncYsvxpKIuP_kRnM5oWXoWLShRn3uDFsM> .
@prefix sub: <http://purl.org/np/RAmwcqsxCeb1ncYsvxpKIuP_kRnM5oWXoWLShRn3uDFsM#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix ns1: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo .
}

sub:assertion {
  sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  
  sub:version prov:value "1"^^xsd:integer .
  
  rdf:object ns1:C0001554 "management";
    ns1:C0220825 "investigation";
    ns1:C0376636 "management";
    ns1:C1261322 "investigation";
    ns1:C1273870 "management";
    ns1:C1521721 "supporting";
    ns1:C1552578 "investigation";
    ns1:C3273539 "management";
    ns1:C5203670 "COVID-19" .
  
  rdf:predicate ns3:TRIPLE_UID:pg3ngnxg-TRIPLE-ABSTRACT-3 "be" .
  
  rdf:subject ns1:C0007561 "ceftriaxone";
    ns1:C0011777 "dexamethasone";
    ns1:C0015620 "famotidine";
    ns1:C0052796 "azithromycin";
    ns1:C0812732 "azithromycin";
    ns1:C1609165 "tocilizumab";
    ns1:C3885145 "sarilumab" .
  
  rdfs:Triple-UID ns2:TRIPLE_UID:pg3ngnxg-TRIPLE-ABSTRACT-3 "pg3ngnxg-TRIPLE-ABSTRACT-3" .
  
  rdfs:sentence rdfs:label "Chloroquine, hydroxychloroquine, lopinavir/ritonavir, ribavirin, oseltamivir, remdesivir, favipiravir, and umifenovir represent the major repurposed drugs used as potential experimental agents for COVID-19 whereas azithromycin, dexamethasone, tocilizumab, sarilumab, famotidine and ceftriaxone are some of the supporting agents that are under investigation for COVID-19 management." .
  
  rdfs:triple rdfs:label "azithromycin , dexamethasone , tocilizumab , sarilumab , famotidine and ceftriaxone are some of the supporting agents that are under investigation for COVID-19 management" .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-07-25T21:47:41.859535"^^xsd:dateTime .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "P5dwe2r+oSrIrjKD6wqfMmHKgxExT1mCtpvCraWG+ga7GK+YlGyP5FCNCI9TNDqh6HrzUpbC7K/j/BMI642ud+Hhh0mSsR3UY6GX9Jpychy1fpwhTjCYdugUE5LxRvZGv643NWDuNSzIMkvpPkE3Hejh0haLmKjXAdUZ9x3rvv8=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-07-25T21:47:41.859535"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}